ImmuneOnco Biopharmaceuticals (Shanghai) Inc

01541

Company Profile

  • Business description

    ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

  • Contact

    1000 Zhangheng Road
    Unit 15, China (Shanghai) Pilot Free Trade Zone
    Pudong New Area
    Shanghai
    CHN

    T: +86 2138016387

    https://cn.immuneonco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    195

Stocks News & Analysis

stocks

ASX healthcare giant remains well positioned despite share slump

We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks

Australian bank remains overvalued despite strong result

When strong fundamentals meet persistent valuation headwinds.
stocks

Chart of the Week: Soft earnings growth outlook for Australian banks

The latest take from our equity research analysts.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,281.8041.30-0.44%
CAC 408,418.19104.951.26%
DAX 4025,123.43267.281.08%
Dow JONES (US)50,121.4066.74-0.13%
FTSE 10010,514.3042.190.40%
HKSE27,032.54233.84-0.86%
NASDAQ23,066.4736.01-0.16%
Nikkei 22557,639.8410.70-0.02%
NZX 50 Index13,531.4824.200.18%
S&P 5006,941.470.34-0.00%
S&P/ASX 2009,043.5018.50-0.20%
SSE Composite Index4,134.022.030.05%

Market Movers